Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of...
Controversies and disappointing trial results have dampened excitement about an established drug touted as a "game changer" for the novel coronavirus. Elisabeth Mahase asks what the future now holds for hydroxychloroquine Before the covid-19 pandemic hydroxychloroquine was known chiefly as a drug to ...
Hydroxychloroquine does not reduce the risk of dying or improve other outcomes in hospitalised patients treated for covid-19, preliminary results from the UK RECOVERY trial have shown. Announcing the results, Martin Landray, the study's deputy chief investigator, said, "We have concluded that ...
The world is facing a frightening pandemic due to coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with thousands of severe infections and fatalities. Since no therapy has proven effective, an extraordinary race is taking place to ...
Multiple studies provide data that hydroxychloroquine (brand name: Plaquenil) does not provide a medical benefit for hospitalized patients with COVID-19. Hydroxychloroquine, an FDA-approved prescription drug used for malaria, rheumatoid arthritis and lupus erythematosus, has been suggested as a possible ...
and safe dose of HCQ, as well as the minimum duration of treatment in COVID-19; 2) define the profile of patients in whom HCQ would be more likely to be effective (especially in asymptomatic patients and/or at the onset of the first signs of the disease); and 3) conduct one or ...
Hydroxychloroquine has been touted as a potential treatment for COVID-19, but new observational data show it is not only without benefit but it increases death and arrhythmias.
Hydroxychloroquine can be ruled out as a treatment for hospitalised COVID-19 patients—but the World Health Organization said Thursday it was aware of ongoing trials into its value as a preventative measure.
Preliminary studies have suggested HCQ may have utility in fighting COVID-196,7. Distinct possible effects may be related to its function in the treatment of COVID-19 patients: A. anti-virus, B. anti-inflammation, and C. anti-thrombotic. As until now there have been no data indicating HCQ...
The US Food and Drug Administration has authorized clinicians to prescribe chloroquine and hydroxychloroquine for patients admitted to hospital with covid-19, despite warnings from scientific advisers that no randomized controlled trial has been conducted to support the drugs' safety and efficacy in this...